ZEOX · Zeo ScientifiX, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“As of April 30, 2026, based on the factors described above, the Company concluded that there was substantial doubt about its ability to continue to operate as a going concern for the 12 months following the issuance of these financial statements. In addition, the Company's independent registered public accounting firm, in its report on the Company's October 31, 2025 financial statements, has expressed substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jun 15, 2026
One customer — 14.2% of revenue (the six months ended April 30, 2026)
“During the six months ended April 30, 2026, the Company sold products and services totaling approximately $571,000 (14.2%) to a large medical practice group and distributor”
One customer — 12.7% of revenue (the six months ended April 30, 2026)
“and approximately $511,000 (12.7%) to another large medical practice group and distributor.”
One customer — 15.2% of revenue (the six months ended April 30, 2025)
“$341,000 (15.2%)”
One customer — 12.1% of revenue (the six months ended April 30, 2025)
“During the six months ended April 30, 2025, the Company sold products and services totaling approximately $270,000 (12.1%) to a large distributor”
One customer — 10.2% of revenue (the six months ended April 30, 2025)
“and $228,000 (10.2%) to two individual medical practices.”
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-10 | Grey Wendy |
10% Owner |
Award↑
Filing footnotes — Stock Options (Indirect)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Plan. The options vested in full as of the grant date, are exercisable on a "cashless basis" for a period of ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. Securities issued by Issuer to Greyt Ventures, LLC, a principal stockholder and consultant to the Issuer. Greyt Ventures, LLC is owned by a trust for which Ms. Grey is trustee. |
Stock Options
(I)
|
625,000 |
| 2026-06-10 | BOTHWELL IAN T |
Director, CEO & CFO, 10% Owner |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under the 2021 Plan. The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis" during the period commencing on the date they vest and ending ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. The options are antidilutive for any future transaction that provides for the issuance of 10% or more of the Company's common stock outstanding on a fully diluted basis. |
Stock Options
|
625,000 |
| 2026-06-10 | Shapiro George Craig |
Director, Chief Medical Officer |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under the 2021 Plan. The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis" during the period commencing on the date they vest and ending ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. The options are antidilutive for any future transaction that provides for the issuance of 10% or more of the Company's common stock outstanding on a fully diluted basis. |
Stock Options
|
625,000 |
| 2026-06-10 | Shapiro George Craig |
Director, Chief Medical Officer |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date, are exercisable on a "cashless basis" for a period of ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. |
Stock Options
|
625,000 |
| 2026-06-10 | Bretz Charles Luther |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date and are subject to the other terms and conditions of the 2021 Plan. |
Stock Options
|
80,000 |
| 2026-06-10 | BOTHWELL IAN T |
Director, CEO & CFO, 10% Owner |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date, are exercisable on a "cashless basis" for a period of ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. |
Stock Options
|
625,000 |
| 2026-06-10 | Grey Wendy |
10% Owner |
Award↑
Filing footnotes — Stock Options (Indirect)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis" during the period commencing on the date they vest and ending ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. The options are antidilutive for any future transaction that provides for the issuance of 10% or more of the Company's common stock outstanding on a fully diluted basis. Securities issued by Issuer to Greyt Ventures, LLC, a principal stockholder and consultant to the Issuer. Greyt Ventures, LLC is owned by a trust for which Ms. Grey is trustee. |
Stock Options
(I)
|
625,000 |
| 2026-01-14 | Shapiro George Craig |
Director, Chief Medical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents the grant of restricted shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The shares vest 50% on the 8th month anniversary of the grant date and the remaining 50% on the 12th month anniversary. |
Common Stock
|
175,000 |
| 2026-01-14 | Grey Wendy |
10% Owner |
Award↑
Filing footnotes — Common Stock (Indirect)
Represents the grant of restricted shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The shares vest 50% on the 8th month anniversary of the grant date and the remaining 50% on the 12th month anniversary. Securities issued to Greyt Ventures, LLC by Issuer. Greyt Ventures, LLC is owned by a trust for which Ms. Grey is trustee. |
Common Stock
(I)
|
175,000 |
| 2026-01-14 | BOTHWELL IAN T |
Director, CEO & CFO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Represents the grant of restricted shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The shares vest 50% on the 8th month anniversary of the grant date and the remaining 50% on the 12th month anniversary. |
Common Stock
|
175,000 |
| 2025-06-25 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
6,000 |
| 2025-06-20 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
1,002 |
| 2025-06-18 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
3,000 |
| 2025-06-11 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
524 |
| 2025-06-09 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
138 |
| 2025-06-06 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
11,100 |
| 2025-05-23 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
500 |
| 2025-05-21 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
1,000 |
| 2025-05-21 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
2,000 |
| 2025-05-12 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
868 |
| 2025-05-09 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
1,054 |
| 2025-05-08 | Singh Gurvinder Pal |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options under the 2021 Plan. The options vested as to 2,000 shares as of the grant date and will vest as to the remaining 3,000 shares on September 23, 2025. |
Stock Options
|
5,000 |
| 2025-05-08 | Shapiro George Craig |
Director, Chief Medical Officer |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. |
Stock Options
|
55,000 |
| 2025-05-08 | Singh Gurvinder Pal |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. |
Stock Options
|
5,000 |
| 2025-05-08 | GLAUSER STEVEN JERRY |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options under the 2021 Plan. The options vested as to 2,000 shares as of the grant date and will vest as to the remaining 3,000 shares on September 23, 2025. |
Stock Options
|
5,000 |
| 2025-05-08 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
2,578 |
| 2025-05-08 | Bretz Charles Luther |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. |
Stock Options
|
5,000 |
| 2025-05-08 | GLAUSER STEVEN JERRY |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. |
Stock Options
|
5,000 |
| 2025-05-08 | BOTHWELL IAN T |
Director, CEO & CFO, 10% Owner |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. |
Stock Options
|
55,000 |
| 2025-05-08 | Stearn Leathem S |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. |
Stock Options
|
5,000 |
| 2025-05-08 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
5,000 |
| 2025-05-08 | Bretz Charles Luther |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options under the 2021 Plan. The options vested as to 2,000 shares as of the grant date and will vest as to the remaining 3,000 shares on September 23, 2025. |
Stock Options
|
5,000 |
| 2025-05-08 | Grey Wendy |
10% Owner |
Award↑
Filing footnotes — Warrant to purchase Common Stock (Indirect)
The warrants are fully vested as of the grant date. Securities issued to Greyt Ventures, LLC by Issuer. Greyt Ventures, LLC is owned by a trust for which Ms. Grey is trustee. |
Warrant to purchase Common Stock
(I)
|
55,000 |
| 2025-05-08 | Stearn Leathem S |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
Represents the grant of stock options under the 2021 Plan. The options vested as to 2,000 shares as of the grant date and will vest as to the remaining 3,000 shares on September 23, 2025. |
Stock Options
|
5,000 |
| 2025-05-08 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
5,000 |
| 2025-05-07 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
14,459 |
| 2025-05-06 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
500 |
| 2025-05-06 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
500 |
| 2025-05-06 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
1,000 |
| 2025-05-05 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
30,500 |
| 2025-05-01 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
2,400 |
| 2025-04-30 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
949 |
| 2025-04-28 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
1,001 |
| 2025-04-23 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
175 |
| 2025-04-21 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
36 |
| 2025-04-11 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
2,400 |
| 2025-04-04 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
1,000 |
| 2025-04-03 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
4,000 |
| 2025-02-20 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
5,000 |
| 2025-02-11 | Skycrest Holdings, LLC |
Insider |
Buy↑
|
Common Stock
|
2,000 |